In fact, hyperleptinemia is an independent predictor of nonalcoholic steatohepatitis (NASH) in obese humans, and the severity of steatosis, hepatocyte ballooning, as well as nonalcoholic fatty liver disease (NAFLD) activity scores correlate with serum leptin levels [7]. This evidence concerns the gene LEP and metabolic dysfunction-associated steatohepatitis.